Schizophrenia Bulletin Advance Access originally published online on August 8, 2006
Schizophrenia Bulletin 2006 32(4):616-617; doi:10.1093/schbul/sbl020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.
Introduction: Current Research on Co-occurring Substance-Use Disorder in Schizophrenia
Psychiatric Research Center, Department of Psychiatry, Dartmouth Medical School, 2 Whipple Place, Lebanon, NH 03766
| The first 10% of the full text of this article appears below. |
The 5 excellent articles in this section stand on their own as scientific contributions and together highlight important progress in schizophrenia research. The first 2 articles, by Caton and colleagues and by Mueser and colleagues, clarify unique features of 2 co-occurring disorders subgroups and may help us to understand the development and heterogeneity of co-occurrence in ways that lead to prevention and treatment. Caton documents that many individuals who appear to present
1To whom correspondence should be addressed; tel: 603-448-0263, fax: 603-448-3976, e-mail: Robert.E.Drake@dartmouth.edu.